CCM
ROIV icon

Cinctive Capital Management’s Roivant Sciences ROIV Stock Holding History

Cinctive Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8M Sell
226,140
-48,381
-18% -$1.43M 0.29% 102
2026
Q1 		$7.6M Buy
+274,521
New +$7.05M 0.5% 59

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Cinctive Capital Management's ROIV Position: Q2 2026 in Review

Cinctive Capital Management reduced its Roivant Sciences (ROIV) stake by 18% in Q2 2026, selling an estimated $1.43M and leaving 226,140 shares worth $8M. The position accounts for 0.29% of the portfolio, ranked #102.

Cinctive Capital Management first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Cinctive Capital Management held 226,140 shares of Roivant Sciences worth $8M as of Q2 2026.
  • Cinctive Capital Management sold 48,381 Roivant Sciences shares in Q2 2026, an estimated $1.43M.
  • Roivant Sciences made up 0.29% of Cinctive Capital Management's portfolio in Q2 2026, its #102 holding.
  • Cinctive Capital Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.